[{"Assets_0_FY_USD":519945000.0,"CommonStockSharesOutstanding_0_FY_shares":142789000.0,"EarningsPerShareBasic_1_FY_USD":0.87,"EarningsPerShareBasic_4_FY_USD":0.46,"EarningsPerShareDiluted_1_FY_USD":0.85,"EarningsPerShareDiluted_4_FY_USD":0.45,"NetIncomeLoss_1_FY_USD":123882000.0,"NetIncomeLoss_4_FY_USD":62971000.0,"StockholdersEquity_0_FY_USD":208366000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_FY_shares":145633000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":139068000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":141718000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":136419000.0,"Ticker":"HALO","CIK":"1159036","name":"HALOZYME THERAPEUTICS INC","OfficialName":"Halozyme Therapeutics Inc. Common Stock","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"5856719603.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20180220"}]